0|chunk|Identification of Peptide Inhibitors of Enveloped Viruses Using Support Vector Machine
0	18	25 Peptide	Chemical	CHEBI_16670
0	26	36 Inhibitors	Chemical	CHEBI_35222
0	CHEBI-CHEBI	CHEBI_16670	CHEBI_35222

1|chunk|The peptides derived from envelope proteins have been shown to inhibit the protein-protein interactions in the virus membrane fusion process and thus have a great potential to be developed into effective antiviral therapies. There are three types of envelope proteins each exhibiting distinct structure folds. Although the exact fusion mechanism remains elusive, it was suggested that the three classes of viral fusion proteins share a similar mechanism of membrane fusion. The common mechanism of action makes it possible to correlate the properties of self-derived peptide inhibitors with their activities. Here we developed a support vector machine model using sequence-based statistical scores of self-derived peptide inhibitors as input features to correlate with their activities. The model displayed 92% prediction accuracy with the Matthew's correlation coefficient of 0.84, obviously superior to those using physicochemical properties and amino acid decomposition as input. The predictive support vector machine model for self-derived peptides of envelope proteins would be useful in development of antiviral peptide inhibitors targeting the virus fusion process.
1	4	12 peptides	Chemical	CHEBI_16670
1	35	43 proteins	Chemical	CHEBI_36080
1	204	213 antiviral	Chemical	CHEBI_22587
1	259	267 proteins	Chemical	CHEBI_36080
1	419	427 proteins	Chemical	CHEBI_36080
1	498	504 action	Chemical	CHEBI_5133
1	567	574 peptide	Chemical	CHEBI_16670
1	575	585 inhibitors	Chemical	CHEBI_35222
1	714	721 peptide	Chemical	CHEBI_16670
1	722	732 inhibitors	Chemical	CHEBI_35222
1	948	953 amino	Chemical	CHEBI_46882
1	948	958 amino acid	Chemical	CHEBI_33704
1	954	958 acid	Chemical	CHEBI_37527
1	1044	1052 peptides	Chemical	CHEBI_16670
1	1065	1073 proteins	Chemical	CHEBI_36080
1	1108	1117 antiviral	Chemical	CHEBI_22587
1	1118	1125 peptide	Chemical	CHEBI_16670
1	1126	1136 inhibitors	Chemical	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_36080
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_22587
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_5133
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_46882
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_33704
1	CHEBI-CHEBI	CHEBI_16670	CHEBI_37527
1	CHEBI-CHEBI	CHEBI_36080	CHEBI_22587
1	CHEBI-CHEBI	CHEBI_36080	CHEBI_5133
1	CHEBI-CHEBI	CHEBI_36080	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_36080	CHEBI_46882
1	CHEBI-CHEBI	CHEBI_36080	CHEBI_33704
1	CHEBI-CHEBI	CHEBI_36080	CHEBI_37527
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_5133
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_46882
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_33704
1	CHEBI-CHEBI	CHEBI_22587	CHEBI_37527
1	CHEBI-CHEBI	CHEBI_5133	CHEBI_35222
1	CHEBI-CHEBI	CHEBI_5133	CHEBI_46882
1	CHEBI-CHEBI	CHEBI_5133	CHEBI_33704
1	CHEBI-CHEBI	CHEBI_5133	CHEBI_37527
1	CHEBI-CHEBI	CHEBI_35222	CHEBI_46882
1	CHEBI-CHEBI	CHEBI_35222	CHEBI_33704
1	CHEBI-CHEBI	CHEBI_35222	CHEBI_37527
1	CHEBI-CHEBI	CHEBI_46882	CHEBI_33704
1	CHEBI-CHEBI	CHEBI_46882	CHEBI_37527
1	CHEBI-CHEBI	CHEBI_33704	CHEBI_37527

2|chunk|* The sequences in bold were used in the 75p+75n training set; the rest sequences were used in the 26p+26n test set.

